0001731122-20-000114.txt : 20200210
0001731122-20-000114.hdr.sgml : 20200210
20200210175816
ACCESSION NUMBER: 0001731122-20-000114
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190827
FILED AS OF DATE: 20200210
DATE AS OF CHANGE: 20200210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ray Sharon Kay
CENTRAL INDEX KEY: 0001422412
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09927
FILM NUMBER: 20593214
MAIL ADDRESS:
STREET 1: 1211 N. WESTSHORE BLVD.
STREET 2: SUITE 512
CITY: TAMPA
STATE: FL
ZIP: 33607
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Advanzeon Solutions, Inc.
CENTRAL INDEX KEY: 0000022872
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
IRS NUMBER: 952594724
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3405 W. DR. MARTIN LUTHER KING JR. BLVD.
STREET 2: SUITE 101
CITY: TAMPA
STATE: FL
ZIP: 33607
BUSINESS PHONE: 813-288-4808
MAIL ADDRESS:
STREET 1: 3405 W. DR. MARTIN LUTHER KING JR. BLVD.
STREET 2: SUITE 101
CITY: TAMPA
STATE: FL
ZIP: 33607
FORMER COMPANY:
FORMER CONFORMED NAME: COMPREHENSIVE CARE CORP
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: NEURO PSYCHIATRIC & HEALTH SERVICES
DATE OF NAME CHANGE: 19730501
FORMER COMPANY:
FORMER CONFORMED NAME: NEURO PSYCHIATRIC & HEALTH SERVICES INC
DATE OF NAME CHANGE: 19700402
4
1
ownership.xml
X0306
4
2019-08-27
0
0000022872
Advanzeon Solutions, Inc.
CHCR
0001422412
Ray Sharon Kay
C/O 2901 W. BUSCH BLVD., SUITE 701
TAMPA
FL
33618
1
0
0
0
Common Stock
2019-08-27
4
J
0
2500000
.00
A
3675000
D
The Board of Directors on August 26, 2019, changed the vesting date of the Issuer's Series D Preferred Stock from January 4, 2022 to August 27, 2019. Each share of the Series D Preferred Stock converts into 100,000 shares of the Issuers Common Stock. The Reporting Person owns 25 shares of the Series D Preferred Stock which are convertible into 2, 5000,000 shares of the Issuers' Common Stock at any time.
This amount includes 322,829 shares of common stock, options to purchase 775,000 shares of common stock, 77,171 shares obtainable from the conversion of 244 shares of the Series C Preferred Stock and 2,500,000 shares obtainable from the conversion of 25 shares of Series D Preferred Stock.
/s/ Sharon Kay Ray
2020-01-23